1. Sanford MF, Slanetz PJ, Lewin AA, Baskies AM, Bozzuto L, Branton SA, et al. ACR appropriateness criteria® Evaluation of Nipple Discharge: 2022 update. Journal of the American College of Radiology. 2022 Nov;19(11). doi:10.1016/j.jacr.2022.09.020
2. [NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer Screening and Diagnosis Version 2.2024]. [cited 2024 Jul 12]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf
3. Gupta D, Mendelson EB, Karst I. Nipple discharge: Current clinical and imaging evaluation. American Journal of Roentgenology. 2021 Feb;216(2):330–9. doi:10.2214/ajr.19.22025
4. Patel BK, Lobbes MBI, Lewin J (2018) Contrast enhanced spectral mammography: A review. Seminars in ultrasound, CT, and MRI 39:70-79. Doi:10.1053/j.sult.2017.08.005
5. Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of Digital Mammography alone and Digital Mammography Plus Tomosynthesis in a population-based screening program. Radiology. 2013 Apr;267(1):47–56. doi:10.1148/radiol.12121373
6. Alcock C, Layer GT. Predicting occult malignancy in nipple discharge. ANZ Journal of Surgery. 2010 Sept;80(9):646–9. doi:10.1111/j.1445-2197.2010.05270.x
7. Whelehan P, Ali K, Vinnicombe S, Ball G, Cox J, Farry P, et al. Digital Breast Tomosynthesis: Sensitivity for cancer in younger symptomatic women. The British Journal of Radiology. 2021 Mar 1;94(1119):20201105. doi:10.1259/bjr.20201105
8. Boisserie-Lacroix M, Doutriaux-Dumoulin I, Chopier J, Boyer B, Depetiteville M-P, Hoppe S, et al. Diagnostic accuracy of breast MRI for patients with suspicious nipple discharge and negative mammography and ultrasound: A prospective study. European Radiology. 2021 Apr 13;31(10):7783–91. doi:10.1007/s00330-021-07790-4
9. Lewin JM, Patel BK, Tanna A. Contrast-Enhanced Mammography: A scientific review. Journal of Breast Imaging. 2019 Dec 12;2(1):7–15. doi:10.1093/jbi/wbz074
10. Jochelson MS, Lobbes MB. Contrast-Enhanced Mammography: State of the art. Radiology. 2021 Apr;299(1):36–48. doi:10.1148/radiol.2021201948
11. Dennis MA, Parker S, Kaske TI, Stavros AT, Camp J. Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic mammotome biopsy. American Journal of Roentgenology. 2000 May;174(5):1263–8. doi:10.2214/ajr.174.5.1741263
12. Garg S, Mohan H, Bal A, Attri AK, Kochhar S. A comparative analysis of core needle biopsy and fine‐needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagnostic Cytopathology. 2007 Oct 8;35(11):681–9. doi:10.1002/dc.20721
13. Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H. Cancer incidence in Egypt: Results of the National Population-Based Cancer Registry Program. Journal of Cancer Epidemiology. 2014;2014:1–18. doi:10.1155/2014/437971
14. Egypt - International Agency for Research on Cancer [Internet]. [cited 2024Jun27]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/818-egypt-fact-sheets.pdf
18. Li GZ, Wong SM, Lester S, Nakhlis F. Evaluating the risk of underlying malignancy in patients with pathologic nipple discharge. The Breast Journal. 2018 Mar 8;24(4):624–7. doi:10.1111/tbj.13018
19. Bahl M, Baker JA, Greenup RA, Ghate SV. Diagnostic value of ultrasound in female patients with nipple discharge. American Journal of Roentgenology. 2015 Jul;205(1):203–8. doi:10.2214/ajr.14.13354
20. Ashfaq A, Senior D, Pockaj BA, Wasif N, Pizzitola VJ, Giurescu ME, et al. Validation study of a modern treatment algorithm for nipple discharge. The American Journal of Surgery. 2014 Aug;208(2):222–7. doi:10.1016/j.amjsurg.2013.12.035
21. Sabel MS, Helvie MA, Breslin T, Curry A, Diehl KM, Cimmino VM, et al. Is duct excision still necessary for all cases of suspicious nipple discharge? The Breast Journal. 2011 Dec 30;18(2):157–62. doi:10.1111/j.1524-4741.2011.01207.x
22. Cabioglu N, Hunt KK, Singletary ES, Stephens TW, Marcy S, Meric F, et al. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. Journal of the American College of Surgeons. 2003 Mar;196(3):354–64. doi:10.1016/s1072-7515(02)01606-x
23. Bansal GJ, Young P. Digital Breast Tomosynthesis within a symptomatic “one-stop breast clinic” for characterization of subtle findings. The British Journal of Radiology. 2015 Sept;88(1053):20140855. doi:10.1259/bjr.20140855
24. Labib PL, Gallegos N, Hegarty D. Nipple discharge. BMJ. 2015 Jul 21; doi:10.1136/bmj.h3123
25. Sarica O, Zeybek E, Ozturk E. Evaluation of nipple-areola complex with ultrasonography and magnetic resonance imaging. Journal of Computer Assisted Tomography. 2010 Jul;34(4):575–86. doi:10.1097/rct.0b013e3181d74a88
26. Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. The American Journal of Surgery. 2010 Jul;200(1):73–80. doi:10.1016/j.amjsurg.2009.06.021
27. Lubina N, Schedelbeck U, Roth A, Weng AM, Geissinger E, Hönig A, et al. 3.0 Tesla Breast Magnetic Resonance Imaging in patients with nipple discharge when mammography and Ultrasound Fail. European Radiology. 2014 Nov 30;25(5):1285–93. doi:10.1007/s00330-014-3521-2
28. Avdan Aslan A, Gültekin S. What is the role of Breast MRI in the management of women with pathologic nipple discharge and normal conventional imaging? Irish Journal of Medical Science (1971 -). 2022 Nov 21;192(5):2331–5. doi:10.1007/s11845-022-03230-4
29. Lorenzon M, Zuiani C, Linda A, Londero V, Girometti R, Bazzocchi M. Magnetic resonance imaging in patients with nipple discharge: Should we recommend it? European Radiology. 2010 Nov 30;21(5):899–907. doi:10.1007/s00330-010-2009-y
30. Nakahara H, Namba K, Watanabe R, Furusawa H, Matsu T, Akiyama F, et al. A comparison of Mr Imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer. 2003 Oct;10(4):320–9. doi:10.1007/bf02967652
31. van Gelder L, Bisschops RH, Menke‐Pluymers MB, Westenend PJ, Plaisier PW. Magnetic resonance imaging in patients with unilateral bloody nipple discharge; useful when conventional diagnostics are negative? World Journal of Surgery. 2014 Aug 15;39(1):184–6. doi:10.1007/s00268-014-2701-1
32. Bahl M, Baker JA, Greenup RA, Ghate SV. Evaluation of pathologic nipple discharge: What is the added diagnostic value of MRI? Annals of Surgical Oncology. 2015 Aug 7;22(S3):435–41. doi:10.1245/s10434-015-4792-9
33. Phillips J, Mihai G, Hassonjee SE, Raj SD, Palmer MR, Brook A, et al. Comparative dose of contrast-enhanced spectral mammography (CESM), Digital Mammography, and Digital Breast Tomosynthesis. American Journal of Roentgenology. 2018 Oct;211(4):839–46. doi:10.2214/ajr.17.19036
34. Fakhry S, Abdel Rahman RW, Shaalan HS, Hassan MH, Tealab SH, Sayed SB. The added role of contrast-enhanced spectral mammography in the evaluation of pathological nipple discharge. Egyptian Journal of Radiology and Nuclear Medicine. 2022 Apr 12;53(1). doi:10.1186/s43055-022-00766-4
35. Homesh NA, Issa MA, El-Sofiani HA. The diagnostic accuracy of fine needle aspiration cytology versus core needle biopsy for palpable breast lump(s). Saudi Med J 2005;26:42-6.
36. Liberman L, Tornos C, Huzjan R, Bartella L, Morris EA, Dershaw DD. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol. 2006;186(5):1328-1334
37. Rissanen T, Reinikainen H, Apaja-Sarkkinen M. Breast sonography in localizing the cause of nipple discharge. Journal of Ultrasound in Medicine. 2007 Aug;26(8):1031–9. doi:10.7863/jum.2007.26.8.1031
38. Mendoza P, Lacambra M, Tan P-H, Tse GM. Fine needle aspiration cytology of the breast: The nonmalignant categories. Pathology Research International. 2011 May 19;2011:1–8. doi:10.4061/2011/547580
39. Cytology [Internet]. [cited 2024 Jul 15]. Available from: https://www.pathologyoutlines.com/topic/breastcytology.html
40. Lehman CD, Lee CI, Loving VA, Portillo MS, Peacock S, DeMartini WB. Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age. American Journal of Roentgenology. 2012 Nov;199(5):1169–77. doi:10.2214/ajr.12.8842
41. Osako T, Iwase T, Takahashi K, lijima K, Miyagi Y, Nishimura S, et al. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years. Breast Cancer. 2007 Jul;14(3):255–9. doi:10.2325/jbcs.14.255
42. Yue D, Swinson C, Ravichandran D. Triple assessment is not necessary in most young women referred with breast symptoms. The Annals of The Royal College of Surgeons of England. 2015 Sept 1;97(6):466–8. doi:10.1308/rcsann.2015.0019
43. Lee WK, Chung J, Cha E, Lee JE, Kim JH (2016) Digital breast tomosynthesis and breast ultrasound: Additional roles in dense breasts with category 0 at conventional digital mammography. European journal of radiology 85:291-296. Doi:10.1016/j.ejrad.2015.09.026
44. Pötsch N, Vatteroni G, Clauser P, Helbich TH, Baltzer PAT (2022) Contrast-enhanced mammography versus contrast-enhanced breast MRI: A systematic review and meta-analysis. Radiology 305:94. Doi:10.1148/radiol.212530
45. Coffey K, Jochelson MS (2022) Contrast-enhanced mammography in breast cancer screening. European journal of radiology 156:110513. Doi:10.1016/j.ejrad.2022.110513